ORALLY-BIOAVAILABLE NUCLEOSIDE ANALOGS
Publication
EP4355755A1
Kind: A1
Mar 18, 2026
Applicants
Venatorx Pharmaceuticals, Inc.
Inventors
BURNS, Christopher J., COBURN, Glen, CHU, Guo-Hua, CONDON, Stephen M., BOYD, Steven A., PEVEAR, Daniel C.
IPC Classifications
C07H 13/12 20060101AFI20250401BHEP
A61P 31/14 20060101ALI20250401BHEP
C07H 13/04 20060101ALI20250401BHEP
C07H 13/06 20060101ALI20250401BHEP
C07H 15/04 20060101ALI20250401BHEP
C07H 15/06 20060101ALI20250401BHEP
C07H 19/073 20060101ALI20250401BHEP
C07H 19/167 20060101ALI20250401BHEP
C07H 19/173 20060101ALI20250401BHEP
C07H 19/20 20060101ALI20250401BHEP
C07H 7/06 20060101ALI20250401BHEP
A61K 31/706 20060101ALI20250401BHEP
C07D 487/04 20060101ALI20250401BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR